Justin Chakma

Justin Chakma is a life sciences venture capital investor with Thomas, McNerney & Partners in La Jolla, CA. He has published over 20 articles in peer-reviewed journals on healthcare policy and innovation, including the New England Journal of Medicine.

Recent posts

U.S. Biomedical Research at a Precipice
[Editor’s Note: this post was co-authored by Justin Chakma, Dr. Reshma Jagsi, and Stephen M. Sammut.]
Since 1950, U.S. government funding has supported research underlying 84 percent of Nobel... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Flagship Adds $1.1B for New Meds, More AI, & “Health Security”

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Iteos Therapeutics Adds $125M to Advance Next-Gen Immunotherapies

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Celularity to Test Natural Killer Cell Therapy for Cancer Against COVID

A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy

Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic

With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

Biogen’s Anirvan Ghosh to Succeed Keith Leonard as Unity Bio CEO

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More

Xcelerating Life Sciences Boston (interactive online event)

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Justin Chakma

Recent posts

U.S. Biomedical Research at a Precipice

Underwriters and Partners

How to Approach Life Sciences Fundraising

2019 Biopharma Outlook – Facing an Uncertain Future

What’s Next in Neuroscience Therapies

Xconomy on Demand

We offer a number of ways to subscribe for free!